Showing results (91-100 of 370) with videos related to

Sort By:
Pageof 37
Pharmacognosy Magazine|November 17, 2017
Constituents and Antioxidant Activity of Bleeding Sap from Various Xinjiang GrapesLv Le, Anwar Umar, Arkin Iburaim, et al.
European Journal of Clinical Pharmacology|November 2, 2012
Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countriesEmilie Clay, Bruno Falissard, Nicholas Moore, et al.
Frontiers in Cardiovascular Medicine|June 27, 2025
Impact of cardiac rehabilitation and treatment compliance after ST-segment elevation myocardial infarction (STEMI) in France, the STOP SCA+ studyEmeline Laurent, Lucile Godillon, Marc-Florent Tassi, et al.
Therapie|March 13, 2019
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in FranceAnne Bénard-Laribière, Pernelle Noize, Pierre-Oliver Girodet, et al.
Journal of Clinical Epidemiology|June 19, 2003
A simple method to estimate sample sizes for safety equivalence studies using inverse samplingNicholas Moore, Pascale Tubert-Bitter, Anne Fourrier, et al.
International Clinical Psychopharmacology|February 13, 2007
Cost-effectiveness of escitalopram vs. citalopram in major depressive disorderBruno Fantino, Nicholas Moore, Hélène Verdoux, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2022
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancerPietro Rosellini, Samuel Amintas, Charline Caumont, et al.
Therapeutic Drug Monitoring|July 27, 2002
Pharmacokinetic interaction between high-dose methotrexate and oxacillinKarine Titier, Fabrice Lagrange, Fabienne Péhourcq, et al.
Australasian Journal on Ageing|October 9, 2025
Hot Stuff: Exploring the Association Between Hot Days and Emergency Department Presentations Amongst Older PatientsCarol Lu Hunter, Nicholas Moore, Paul Middleton, et al.
Pageof 37